Market Cap: $8.98B
Market Cap: $8.98B
Open
$125.36
Prev. Close
$140.33
High
$126.22
Low
$124.18
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets.
AptarGroup, Inc. trades on the New York Stock Exchange under the ticker ATR, priced in USD.
AptarGroup, Inc. has a market capitalisation of $8.98B, based on its latest share price.
ATR trades at 33.90 times its trailing 12-month earnings.
Over the past 52 weeks ATR has traded between $110.95 and $148.63.
Yes. AptarGroup, Inc.'s dividend yields 1.38% at the current share price, paying out 46% of its earnings.
Profitable, with a net margin of 6.7% over the last 12 months.
The analyst consensus rating for ATR is Buy. Analysts' average 12-month price target of $162.67 implies 15% upside.
Gael Touya is the CEO of AptarGroup, Inc., which is headquartered in Crystal Lake.
Generated automatically from reported financial data. General information only, not financial advice.

AptarGroup, Inc. ( ATR ) is navigating the complexities of modern markets through a keen focus on innovation and sustainability. This strategic approach not only defines the company's product offering…

AptarGroup, Inc. has made a significant move in the packaging industry with the launch of its new line of inverted lidless dispensing closures. Utilizing the innovative SimpliSqueeze valve technology,…

AptarGroup (ATR) has received recognition as one of America's Climate Leaders for the fourth consecutive year, underlining the company's commitment to environmental sustainability and emissions reduct…
Aptar Digital Health announces a pivotal partnership with Enable Injections, Inc., positioning itself as the preferred digital health partner for Enable’s enFuse® wearable infusion system. This strate…